Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$33.36 - $45.71 $33,360 - $45,710
1,000 Added 25.0%
5,000 $224,000
Q1 2023

Apr 11, 2023

SELL
$34.96 - $43.94 $69,920 - $87,880
-2,000 Reduced 33.33%
4,000 $176,000
Q3 2022

Oct 17, 2022

SELL
$47.75 - $66.88 $191,000 - $267,520
-4,000 Reduced 40.0%
6,000 $291,000
Q3 2021

Oct 14, 2021

SELL
$38.45 - $55.66 $230,700 - $333,960
-6,000 Reduced 37.5%
10,000 $395,000
Q3 2020

Nov 09, 2020

SELL
$57.51 - $75.36 $115,020 - $150,720
-2,000 Reduced 11.11%
16,000 $1.21 Million
Q1 2020

May 06, 2020

SELL
$26.79 - $38.99 $133,950 - $194,950
-5,000 Reduced 21.74%
18,000 $629,000
Q4 2019

Jan 10, 2020

SELL
$29.07 - $35.63 $84,448 - $103,505
-2,905 Reduced 11.21%
23,000 $669,000
Q4 2018

Feb 07, 2019

BUY
$17.56 - $21.2 $454,891 - $549,186
25,905 New
25,905 $516,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $582M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Canton Hathaway, LLC Portfolio

Follow Canton Hathaway, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canton Hathaway, LLC with notifications on news.